Augmented analytics

Graph neural networks (GNNs) offer transformative potential for businesses by uncovering hidden patterns and relationships within complex data. From detecting fraud to optimizing supply chains and accelerating drug discovery, GNNs enable smarter decision-making and drive operational efficiency. Unlike traditional machine learning models that analyze data points in isolation, GNNs excel at identifying connections and patterns within the data. For business leaders, this technology presents an opportunity to unlock new avenues for growth and innovation, maximizing the potential of their data.

The ability to leverage the combined strengths of machine learning and optimization to enhance decision-making processes can significantly transform business operations. By integrating these technologies, businesses can achieve increased efficiency, reduce operational costs, and improve overall outcomes. This transformative potential is realized through practical applications in decision-making, whether by supporting human decisions or performing them autonomously.

Effective ESG reporting is crucial for transparency and for meeting regulatory requirements, such as the new Corporate Sustainability Reporting Directive (CSRD) in the EU, and attracting investors. In this context, artificial intelligence can be a powerful tool to transform and enhance this reporting, providing accurate, comprehensive, and real-time insights. By automating complex processes and delivering deeper insights, AI can support organizations in improving their ESG performance and transparency, paving the way for more sustainable and responsible business practices.

Mats Andersson, a PhD student at Sahlgrenska Academy's neuroscience department, is researching how synapses in the brain work. This research is important for understanding conditions where synaptic turnover is affected, such as autism, schizophrenia, and depression, as well as neurodegenerative diseases like Alzheimer's and Parkinson's. Using cutting-edge tools and collaborating with other scientists, this research aims to make a real difference in understanding and eventually treating or managing these conditions.